Search research articles
Contact Us
Filters
Showing results (11-20 of 22) with videos related to
Page
of 3
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 27, 2017
Assessing treatment efficacy in the subset of responders in a randomized clinical trial
E L Korn, M Othus, T Chen, et al.
Human Heredity
|
July 30, 2002
Trend tests for case-control studies of genetic markers: power, sample size and robustness
B Freidlin, G Zheng, Z Li, et al.
Cancer
|
March 16, 2000
Increased incidence rates but no space-time clustering of childhood astrocytoma in Sweden, 1973-1992: a population-based study of pediatric brain tumors
M A Smith, B Freidlin, L A Ries, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 24, 1999
Second malignancies as a consequence of nucleoside analog therapy for chronic lymphoid leukemias
B D Cheson, D A Vena, J Barrett, et al.
Journal of the National Cancer Institute
|
September 10, 1998
Trends in reported incidence of primary malignant brain tumors in children in the United States
M A Smith, B Freidlin, L A Ries, et al.
Journal of the National Cancer Institute
|
August 6, 1997
Accelerated titration designs for phase I clinical trials in oncology
R Simon, B Freidlin, L Rubinstein, et al.
Cancer
|
October 1, 1994
Representation of older patients in cancer treatment trials
E L Trimble, C L Carter, D Cain, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
August 26, 1998
Clustering of non-major histocompatibility complex susceptibility candidate loci in human autoimmune diseases
K G Becker, R M Simon, J E Bailey-Wilson, et al.
Journal of Cellular Biochemistry
|
October 1, 1996
Oncogene alterations in primary, recurrent, and metastatic human bone tumors
F Pompetti, P Rizzo, R M Simon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 17, 2001
Twenty-two years of phase III trials for patients with advanced non-small-cell lung cancer: sobering results
O S Breathnach, B Freidlin, B Conley, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 22) with videos related to
Sort By:
Page
of 3
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 27, 2017
Assessing treatment efficacy in the subset of responders in a randomized clinical trial
E L Korn, M Othus, T Chen, et al.
Human Heredity
|
July 30, 2002
Trend tests for case-control studies of genetic markers: power, sample size and robustness
B Freidlin, G Zheng, Z Li, et al.
Cancer
|
March 16, 2000
Increased incidence rates but no space-time clustering of childhood astrocytoma in Sweden, 1973-1992: a population-based study of pediatric brain tumors
M A Smith, B Freidlin, L A Ries, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 24, 1999
Second malignancies as a consequence of nucleoside analog therapy for chronic lymphoid leukemias
B D Cheson, D A Vena, J Barrett, et al.
Journal of the National Cancer Institute
|
September 10, 1998
Trends in reported incidence of primary malignant brain tumors in children in the United States
M A Smith, B Freidlin, L A Ries, et al.
Journal of the National Cancer Institute
|
August 6, 1997
Accelerated titration designs for phase I clinical trials in oncology
R Simon, B Freidlin, L Rubinstein, et al.
Cancer
|
October 1, 1994
Representation of older patients in cancer treatment trials
E L Trimble, C L Carter, D Cain, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
August 26, 1998
Clustering of non-major histocompatibility complex susceptibility candidate loci in human autoimmune diseases
K G Becker, R M Simon, J E Bailey-Wilson, et al.
Journal of Cellular Biochemistry
|
October 1, 1996
Oncogene alterations in primary, recurrent, and metastatic human bone tumors
F Pompetti, P Rizzo, R M Simon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 17, 2001
Twenty-two years of phase III trials for patients with advanced non-small-cell lung cancer: sobering results
O S Breathnach, B Freidlin, B Conley, et al.
Page
of 3